Outsourcing the Safe Development & Manufacture of ADCs: Perspectives from the CMOs & Drug Innovators

Time: 1:30 pm
day: Track C - Day 1 PM

Details:

  • How the hazards of ADCs and their components are evaluated
  • Procedures for handling these compounds safely
  • Information to be exchanged between the drug innovator and CMO to ensure that safe manufacture takes place

 

Speakers: